Skip to main content
. Author manuscript; available in PMC: 2016 Jun 6.
Published in final edited form as: Aliment Pharmacol Ther. 2014 Apr 30;39(12):1408–1417. doi: 10.1111/apt.12774

Figure 2.

Figure 2

Cumulative incidence of subsequent colorectal neoplasia (CRN) for: (a) All serrated epithelial change patients (—SEC all) compared to IBD controls (- - Ctrl all); (b) serrated epithelial change patients with a history of prior or synchronous CRN (— SEC with prior CRN) compared to IBD controls with prior CRN (- - Ctrl with prior CRN); and (c) serrated epithelial change patients without history of prior or synchronous CRN (— SEC without prior CRN) compared to IBD controls without prior colorectal neoplasia (- - Ctrl without prior CRN).